Rhaeos, Inc. Awarded $4 Million NIH SBIR Grant to Expand Quantitative Measurement Capabilities of its FlowSense™ Noninvasive Wireless Sensor
- Rhaeos, Inc.
EVANSTON, Ill., Sept. 16, 2021 /PRNewswire/ — Rhaeos, Inc., a private medical device company focused on the care of patients with hydrocephalus, announced today it was awarded a $4 million, multi-year grant from the National Institutes of Health (NIH) Small Business Innovation Research (SBIR) program through the National Institute of Neurological Disorders and Stroke (NINDS). Grant funds will be used to expand the functionality of its FlowSense™ wireless noninvasive sensor to provide flow rate measurements and other quantitative data.. Read more…
Related Reading
Resource / Coverage & Payment / Government & Legislative Affairs / Health Access
Gateways to Health: How Medtech Is Improving Care While Lowering Healthcare Costs
July 31, 2026
Read Gateways to Health, a special publication exploring how medical technology improves patient care, expands access, and lowers healthcare costs.
Event / Global & Trade / Regulatory Affairs
Entering the Japanese Medical Device Market: Regulatory Pathways, Consultation Opportunities, and Practical Insights
September 1, 2026 |
7:00 PM – 8:30 PM ET
September 2, 2026 |
8:00 AM – 9:30 AM JST
Learn how to enter Japan’s medtech market with insights on regulatory pathways, consultation services, and practical insights for U.S. medtech companies.
Event / Regulatory Affairs
The Widening AI Gap: Why AI-First MedTech Companies Are Pulling Ahead
July 28, 2026
12:00 PM – 1:00 PM
Join Boston Consulting Group as they explore how medtech organizations are using AI to transform product development and accelerate innovation.
News / Government & Legislative Affairs / Regulatory Affairs
AdvaMed Welcomes Key Developments in MDUFA VI Process
July 8, 2026
WASHINGTON, D.C.—AdvaMed, the Medtech Association, today welcomed next steps in the Medical Device User Fee Amendments reauthorization process following clearance by the White House Office of Management and Budget of the draft MDUFA VI agreement.
News / Small Business
Francis Medical Announces Publication of VAPOR 2 Pivotal Trial Results in The Journal of Urology
July 2, 2026
MAPLE GROVE, Minn., June 30, 2026 — Francis Medical, Inc., a medical device company dedicated to advancing minimally invasive therapies for urological cancers, today announced the publication of the initial report from its VAPOR 2 pivotal clinical study in The Journal of Urology, one of the world’s leading peer-reviewed urology journals.
News / Coverage & Payment / Diagnostics / Digital Health / Government & Legislative Affairs / Health Access / Regulatory Affairs
AdvaMed Statement on the Klomp Nomination
June 26, 2026
WASHINGTON—Scott Whitaker, president and CEO of AdvaMed, the largest trade association representing medtech innovators, posted his statement on LinkedIn regarding the nomination of Chris Klomp as deputy secretary of the Department of Health and Human Services.
Blog / Coverage & Payment / Digital Health / Government & Legislative Affairs / Health Access / Regulatory Affairs
Essential Tremor Treatment: A Sensible Solution, Possibly Driven Out of Reach
June 22, 2026
Millions of Americans have the neurological condition essential tremor. Often, that means their hand shakes so badly, they can’t hold a pen, fork, or glass of water. Every activity of daily living is compromised, day and night.
Resource / China / Global & Trade / Regulatory Affairs / Standards
China GMP and ISO 13485: A Side-by-Side Comparison
June 22, 2026
China GMP and ISO 13485: A Side-by-Side Comparison